Benign prostatic hyperplasia (BPH) occurs in elderly men who will occupy 15-25% of a population after next two decades. By the age of 60 years 50% are affected and approximately 50% of them would develop varying degree of lower urinary tract symptoms (LUTS) and other complications of bladder outlet obstruction. BPH and its related lower urinary tract symptoms cause significant level of morbidity and often have measurable decrement in the Quality of Life of those who are affected (1,2).
Benign prostatic hyperplasia (BPH) occurs in elderly men who will occupy 15-25% of a population after next two decades. By the age of 60 years 50% are affected and approximately 50% of them would develop varying degree of lower urinary tract symptoms (LUTS) and other complications of bladder outlet obstruction. BPH and its related lower urinary tract symptoms cause significant level of morbidity and often have measurable decrement in the Quality of Life of those who are affected (1, 2) .
An important goal in treating men with BPH is to relieve bothersome symptoms and avoid complications and to increase the quality of life. Currently, mainstreams of management are transurethral endosurgical ablation of the adenoma or involution and relaxation of tissues by drugs such as finasteride and alpha adrenergic blockers respectively. Uncomplicated mildly symptomatic patients are also managed expectantly with lifestyle adjustments (3, 4) . It is observed that due to its minimal initial complications medical therapy has been offered to patients by a wide range of clinicians (apart from urologists) without proper assessment of the presenting problem or outcome of this relatively new therapeutic option.
Unfortunately, in Sri Lanka, selection of patients for the optimum treatment modality is still done on a very much subjective manner which depends heavily on the patient's often temperamental perception of his symptomatic bother and the clinician's personal experience which is often subjective to individual variation. Objective scoring systems such as International Prostate Symptom Score (IPSS) and basic urodynamics (post voidal residual and uroflowmetry) used in the west are not applied in Sri Lanka on a regular basis which could lead to faulty decision making (5,7,10).
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The main purpose of the present study is to assess the applicability of an objective scoring system to the current decision making which is done mostly on clinical judgment. It was also attempted to find objectively the outcome of two main treatment modalities for BPH (namely medical and surgical therapy). Furthermore, an attempt was made to stratify patients according to the severity of the disease so that optimal treatment option could be decided more objectively.
Patients and methods
Data were collected using an interviewer-administered questionnaire after obtaining the informed verbal consent from subjects. The questionnaire consisted of three parts: socio-demographic data, objective pre and post interventional data and treatment details. Sinhala and Tamil translated version of the International Prostate Symptom Score (IPSS) and simple urodynamic studies using post void residue and uroflowmetry were used for assessment. Pilot study and pre testing with 20 patients led to few modifications such as changing the sequence of questions, new questions regarding the post interventional investigations.
Linguistic validation process was carried to translate the IPSS into native languages (Sinhala and Tamil).
All the data collectors used the same translation and scoring system and asked all questions as they were in the questionnaires and translation in order to reduce the interviewing bias.
Data analysis done by a database was created using SPSS 15.0. The collected data analyzed using t test, chi square and Spearman's correlation.
Ethical clearance was obtained from the ethical grants committee of the hospital.
Results
During the study period of two months out of 84 people who visited the BPH clinic for their follow up, 78 patients were taken for our study. Six patients were excluded according to our exclusion criteria such as presence of carcinoma, urethral strictures unrelated neuropathic bladders. Only 66 patients were taken for the analysis with all the investigation results. Patients who were not very cooperative were also excluded from the study. Out of 66 patients 33 patients had been managed with medical treatment and 33 were managed surgically. Mean age of the patients were 62.52 and 69.0 for medical and surgical management respectively.
For comparison purposes patients were divided into the following groups
• IPSS mild, moderate and severe symptom groups, • PVR normal, insignificant and significant, • Qmax normal, mild, moderate and severe impairment.
IPSS was also categorized as mild, moderate and severe when the total IPSS score become <7, 8-19 and 20-35 respectively. In our study we used the questionnaire along with the Sinhala translation of the IPSS score which we developed after going through the linguistic validation process and grouped them in to mild, moderate and severe groups according to it ( Table 1) . The present study demonstrate that the translated version of IPSS has a highly significant correlation with the QOL both pre and post intervention (p<0.001), (Table 1, 5) . Overall pre interventional IPSS was higher in population who were managed surgically and pre interventional QOL was lower in surgically managed patients than those who were managed medically with a significant difference between these two groups (p<0.05) ( Medical therapy Surgical therapy the urodynamic assessments (9) . In spite of this fact out of thirty six patients in severe IPSS grading only 63.9% were managed surgically. In the same context 20% of patients with mild symptoms were subjected to surgery without clear reasons. It was observed that surgery has achieved better results in all post parameters in the present study. This is demonstrated by higher post interventional IPSS, lower QOL, lesser Qmax and PVR improvement observed in the medically managed population compared to surgically managed patients (Table 5 ). This observation was more intensified in severe IPSS group in which 11 patients improved after the surgery compared to only 2 patients improved on medically managed group (p=0.05) ( Table 6 ).
These observations compare well with other studies done in foreign languages (8) .
A similar superiority of surgical therapy was observed ( (Table 2) . Present study affirms the fact that surgical ablation offers superior results to prolonged medical therapy both in symptomatic and urodynamic parameters. In the absence of objective assessment in the follow up of medically managed patients this fact may not be appreciated by the clinician, leading the patient to suffer in silence until a complication such as acute retention takes place.
When considering the fact of decision making based on simple urodynamic measures such as uroflowmetry and postvoid residual urine in the bladder it is interesting to find that the correlation between IPSS and the premanagement Qmax was very week. and there was no significant correlation between pre-management IPSS with the %PVR score itself. These findings suggest that isolated measurement of PVR and the Qmax were not correlated with the QOL of the patients prior to their management. Hence, decisions to treat based on these findings could be erroneous (9) (10) (11) (12) (13) (14) . These observations which are shared by others (15, 17) are exemplified by the fact that 37.5% with mild Qmax which theoretically do not need surgery for outlet obstruction were treated surgically. In the same context 26% patients with severe urine flow impairment were treated with medical therapy which again would not be the best choice of treatment. This demonstrates the lack of standardisaton in decision making. Contrary to the judgment made by using pure clinical sense, we found that while the Qmax weakly correlated with IPSS Table 4) .
Conclusions
Traditional decision making based on non categorized symtomatology does not offer the patient the best method of treatment to improve his urological QOL. Standardization and uniformity in decision making to offer medical or surgical therapy needs a validated objective scoring system and pure clinical judgment could lead to errors in decision making. All clinicians who undertake treatment of symptomatic BPE should realize the complexity of pre treatment assessment to avoid offering a suboptimal treatment option. Most widely used symptom scoring systems such as IPSS can be translated and validated in native languages.
Application of these scoring systems should be made mandatory in the initial clinical assessment, treatment decision making and in the follow up assessment. Simple urodynamic test though clinically useful when used alone do not predict the effect on QOL hence should not be used in isolation for treatment decision making. Severe symptom scores and urodynamic impairment are best treated with surgical therapy.
Stratification of patients according to the severity of symptomatic and urodynamic parameters in this study is more rational than just considering averages for comparison. We suggest wider application of this stratified comparison in future studies of this nature.
